Skye Bioscience Inc
NASDAQ:SKYE

Watchlist Manager
Skye Bioscience Inc Logo
Skye Bioscience Inc
NASDAQ:SKYE
Watchlist
Price: 5.39 USD -2% Market Closed
Market Cap: 163.5m USD
Have any thoughts about
Skye Bioscience Inc?
Write Note

Skye Bioscience Inc
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Skye Bioscience Inc
Interest Income Expense Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Skye Bioscience Inc
NASDAQ:SKYE
Interest Income Expense
-$129.4k
CAGR 3-Years
42%
CAGR 5-Years
39%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Interest Income Expense
-$2B
CAGR 3-Years
7%
CAGR 5-Years
-9%
CAGR 10-Years
-13%
Gilead Sciences Inc
NASDAQ:GILD
Interest Income Expense
-$948m
CAGR 3-Years
26%
CAGR 5-Years
-6%
CAGR 10-Years
-10%
Amgen Inc
NASDAQ:AMGN
Interest Income Expense
-$2.4B
CAGR 3-Years
-34%
CAGR 5-Years
-29%
CAGR 10-Years
-15%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Interest Income Expense
$595.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Interest Income Expense
$990m
CAGR 3-Years
23%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Skye Bioscience Inc's Interest Income Expense?
Interest Income Expense
-129.4k USD

Based on the financial report for Jun 30, 2024, Skye Bioscience Inc's Interest Income Expense amounts to -129.4k USD.

What is Skye Bioscience Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
39%

Over the last year, the Interest Income Expense growth was 76%. The average annual Interest Income Expense growth rates for Skye Bioscience Inc have been 42% over the past three years , 39% over the past five years .

Back to Top